Gypenoside protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of mitogen-activated protein kinase mediated nuclear factor kappa B pathway in vitro and in vivo

• Main Authors: Haijie eYu (Author), liye eshi (Author), guoxian eqi (Author), shijie ezhao (Author), yuan egao (Author), yuzhe eli (Author)
• Format: Book
• Published: Frontiers Media S.A., 2016-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gypenoside (GP) is the major effective component of Gynostemma pentaphyllum and has been shown to encompass a variety of pharmacological activities. In this study, we investigated whether GP is able to protect cardiomyocytes against injury myocardial ischemia-reperfusion (I/R) injury by using in vit...